Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma
- PMID: 11734433
- DOI: 10.1164/ajrccm.164.10.2010096
Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma
Abstract
Allergic asthma is thought to be the result of an inappropriate specific immune response against common environmental antigens. However, studies of animal asthma models have also linked the innate immune system, in particular complement factors C3a and C5, to murine airway hyperresponsiveness. Because the possible role of these anaphylatoxins in patients with asthma is not understood, we tested the hypothesis that C3a and C5a will increase in the bronchoalveolar lavage (BAL) fluid of patients with asthma after segmental allergen provocation. In a group of 15 subjects with mild asthma we found a significant upregulation of C3a and C5a 24 h after allergen challenge compared with baseline values (p < 0.01). In a control group of healthy volunteers the concentrations remained basically unchanged. Furthermore, we found a strong correlation between both anaphylatoxins and the number of eosinophils (p < 0.01) and, to a lesser degree, with the number of neutrophils (p < 0.05) in BAL fluid. These data suggest a contribution of anaphylatoxins C3a and C5a to the pathogenesis in asthma. However, the pathogenic role of these substances in relation to asthma remains to be elucidated, for example, by using anaphylatoxin receptor blockers as a possible new therapeutic principle.
Similar articles
-
[Immunopathogenesis of allergic bronchial asthma. Detection of activated CD25-CD4 lymphocytes and release of cytokines in the bronchoalveolar space following segmental allergen challenge].Dtsch Med Wochenschr. 1995 Jan 5;120(1-2):10-7. doi: 10.1055/s-2008-1043192. Dtsch Med Wochenschr. 1995. PMID: 7821198 Clinical Trial. German.
-
Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.J Immunol. 2005 Jan 15;174(2):783-9. doi: 10.4049/jimmunol.174.2.783. J Immunol. 2005. PMID: 15634899
-
Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma.Allergy. 2006 May;61(5):598-604. doi: 10.1111/j.1398-9995.2006.01062.x. Allergy. 2006. PMID: 16629790
-
Regulation and function of anaphylatoxins and their receptors in allergic asthma.Mol Immunol. 2017 Apr;84:51-56. doi: 10.1016/j.molimm.2016.11.013. Mol Immunol. 2017. PMID: 27916272 Review.
-
Anaphylatoxin C3a receptors in asthma.Respir Res. 2005 Feb 21;6(1):19. doi: 10.1186/1465-9921-6-19. Respir Res. 2005. PMID: 15723703 Free PMC article. Review.
Cited by
-
Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons.Immunology. 2004 Apr;111(4):435-43. doi: 10.1111/j.1365-2567.2004.01829.x. Immunology. 2004. PMID: 15056381 Free PMC article.
-
Associations between Th17-related inflammatory cytokines and asthma in adults: A Case-Control Study.Sci Rep. 2017 Nov 14;7(1):15502. doi: 10.1038/s41598-017-15570-8. Sci Rep. 2017. PMID: 29138487 Free PMC article.
-
Complement activation pathways: a bridge between innate and adaptive immune responses in asthma.Proc Am Thorac Soc. 2007 Jul;4(3):247-51. doi: 10.1513/pats.200704-046AW. Proc Am Thorac Soc. 2007. PMID: 17607007 Free PMC article. Review.
-
Role of Complement Components in Asthma: A Systematic Review.J Clin Med. 2024 May 22;13(11):3044. doi: 10.3390/jcm13113044. J Clin Med. 2024. PMID: 38892755 Free PMC article. Review.
-
Complement's involvement in allergic Th2 immunity: a cross-barrier perspective.J Clin Invest. 2025 May 1;135(9):e188352. doi: 10.1172/JCI188352. eCollection 2025 May 1. J Clin Invest. 2025. PMID: 40309766 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous